Sloan-Kettering Institute for Cancer Research;Aragon Pharmaceuticals, Inc.
发明人:
申请号：
EP13800681.2
公开号：
EP2858985B1
申请日:
2013.06.04
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Described herein are crystalline forms of the androgen receptor modulated 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3,4]oct-5-yl]-2-fluoro-N-methylbenzamide, pharmaceutically acceptable salts, solvates, as well as pharmaceutical compositions thereof, and the same for use in treatment or prevention of diseases or conditions associated with androgen receptor activity.
